1767.50SEKMkt Cap: 2.74T SEKP/E: 28.27Last update: 2026-05-21
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza,…
Industry Peers
Drug Manufacturers - Generalloading…
Indicators:|
Key Statistics
Company
Market Cap2.74T SEK
Enterprise Value2.76T SEK
Revenue (TTM)60.44B SEK
Gross Profit48.11B SEK
Net Income (TTM)10.22B SEK
Revenue/Share39.00 SEK
Last Price1767.50 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees96.1K
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - General
ISINGB0009895292
Valuation
P/E (Trailing)28.27
P/E (Forward)17.50
PEG1.44
EV/EBITDA138.25
EV/Revenue45.74
P/S45.35
P/B57.84
EPS (TTM)62.52
EPS (Forward)101.02
52W Range
1739.00100% of range1767.50
52W High1767.50 SEK
52W Low1739.00 SEK
Profitability
Gross Margin81.90%
Oper. Margin28.17%
EBITDA Margin33.08%
Profit Margin17.41%
ROE21.01%
ROA8.96%
Growth
Revenue Growth12.50%
Earnings Growth5.30%
Cash Flow & Leverage
Operating CF14.57B SEK
CapEx (TTM)5.91B SEK
FCF Margin10.82%
FCF Yield0.24%
Net Debt26.35B SEK
Net Debt/EBITDA1.32
Balance Sheet
Debt/Equity0.60
Current Ratio0.91
Quick Ratio0.70
Book Value/Sh30.56 SEK
Cash/Share4.955 SEK
Dividends
Fwd Div Rate29.62 SEK
Trail. Div Rate3.200 SEK
Div. Yield1.70%
5Y Avg Yield2.08%
Payout Ratio47.70%
Ex-Div DateFeb 19, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)1846.07 SEK
Target Range1658.96 SEK – 1960.59 SEK
# Analysts3
Ownership
Shares Out.1.55B
Float1.54B
Insiders0.05%
Institutions64.93%
Technical
SMA 501784.22 (-0.9%)
SMA 2001682.77 (+5.0%)
Beta0.22
S&P 52W Chg27.23%
Avg Vol (30d)298.47K
Avg Vol (10d)271.38K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—